Literature DB >> 12960275

Human immunodeficiency virus type 1 (HIV-1) Nef activates STAT3 in primary human monocyte/macrophages through the release of soluble factors: involvement of Nef domains interacting with the cell endocytotic machinery.

Zulema Percario1, Eleonora Olivetta, Gianna Fiorucci, Giorgio Mangino, Silvia Peretti, Giovanna Romeo, Elisabetta Affabris, Maurizio Federico.   

Abstract

Increasing evidence indicates that the expression of the human immunodeficiency virus-1 (HIV-1) Nef protein significantly influences the activation state of the host cell. Here we report that Nef specifically activates STAT3 in primary human monocyte-derived macrophages (MDM). This was demonstrated by both single-cycle infection experiments driven by Vesicular Stomatitis virus glycoprotein (VSV-G) pseudotyped HIV-1 and treatment with exogenous recombinant Nef. The analysis of the effects of Nef mutants revealed that domains of the C-terminal flexible loop interacting with the cell endocytotic machinery are involved in the STAT3 activation. In particular, our data suggest that the Nef-dependent STAT3 activation relies on the targeting of Nef to the late endosome/lysosome compartment. In addition, we found that Nef activates STAT3 through a mechanism mediated by the release of soluble factor(s), including MIP-1alpha, that requires de novo protein synthesis but appears independent from the activation of src tyrosine kinases. The results presented here support the idea that the first intervention of Nef in the intracellular signaling of monocyte-macrophages could generate, by means of the release of soluble factor(s), a secondary wave of activation that could be of a potential pathogenetic significance.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12960275     DOI: 10.1189/jlb.0403161

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  24 in total

1.  Validation of a novel secretion modification region (SMR) of HIV-1 Nef using cohort sequence analysis and molecular modeling.

Authors:  Patrick E Campbell; Olexandr Isayev; Syed A Ali; William W Roth; Ming-Bo Huang; Michael D Powell; Jerzy Leszczynski; Vincent C Bond
Journal:  J Mol Model       Date:  2012-05-30       Impact factor: 1.810

2.  p38 Mitogen-activated protein kinase/signal transducer and activator of transcription-3 pathway signaling regulates expression of inhibitory molecules in T cells activated by HIV-1-exposed dendritic cells.

Authors:  Karlhans Fru Che; Esaki Muthu Shankar; Sundaram Muthu; Sasan Zandi; Mikael Sigvardsson; Jorma Hinkula; Davorka Messmer; Marie Larsson
Journal:  Mol Med       Date:  2012-10-24       Impact factor: 6.354

3.  Secretion modification region-derived peptide disrupts HIV-1 Nef's interaction with mortalin and blocks virus and Nef exosome release.

Authors:  Martin N Shelton; Ming-Bo Huang; Syed A Ali; Michael D Powell; Vincent C Bond
Journal:  J Virol       Date:  2011-10-19       Impact factor: 5.103

Review 4.  Risk of coronary heart disease in patients with HIV infection.

Authors:  Markella V Zanni; Judith Schouten; Steven K Grinspoon; Peter Reiss
Journal:  Nat Rev Cardiol       Date:  2014-10-21       Impact factor: 32.419

5.  Nef inhibits glucose uptake in adipocytes and contributes to insulin resistance in human immunodeficiency virus type I infection.

Authors:  Laura Cheney; June C Hou; Sidonie Morrison; Jeffrey Pessin; Roy T Steigbigel
Journal:  J Infect Dis       Date:  2011-06-15       Impact factor: 5.226

6.  In vitro treatment of human monocytes/macrophages with myristoylated recombinant Nef of human immunodeficiency virus type 1 leads to the activation of mitogen-activated protein kinases, IkappaB kinases, and interferon regulatory factor 3 and to the release of beta interferon.

Authors:  Giorgio Mangino; Zulema A Percario; Gianna Fiorucci; Gabriele Vaccari; Santiago Manrique; Giovanna Romeo; Maurizio Federico; Matthias Geyer; Elisabetta Affabris
Journal:  J Virol       Date:  2006-12-20       Impact factor: 5.103

7.  HIV-1 Nef regulates the release of superoxide anions from human macrophages.

Authors:  Eleonora Olivetta; Donatella Pietraforte; Ilaria Schiavoni; Maurizio Minetti; Maurizio Federico; Massimo Sanchez
Journal:  Biochem J       Date:  2005-09-01       Impact factor: 3.857

Review 8.  HIV-specific immune dysregulation and atherosclerosis.

Authors:  Markella V Zanni; Steven K Grinspoon
Journal:  Curr HIV/AIDS Rep       Date:  2012-09       Impact factor: 5.071

Review 9.  Macrophage signaling in HIV-1 infection.

Authors:  Georges Herbein; Gabriel Gras; Kashif Aziz Khan; Wasim Abbas
Journal:  Retrovirology       Date:  2010-04-09       Impact factor: 4.602

10.  Microglia-derived HIV Nef+ exosome impairment of the blood-brain barrier is treatable by nanomedicine-based delivery of Nef peptides.

Authors:  A D Raymond; P Diaz; S Chevelon; M Agudelo; A Yndart-Arias; H Ding; A Kaushik; R Dev Jayant; R Nikkhah-Moshaie; U Roy; S Pilakka-Kanthikeel; M P Nair
Journal:  J Neurovirol       Date:  2015-12-02       Impact factor: 2.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.